U.S. markets open in 1 hour 26 minutes

InMed Pharmaceuticals Inc. (IN.TO)

Toronto - Toronto Real Time Price. Currency in CAD
Add to watchlist
4.4000-0.3400 (-7.17%)
At close: 3:55PM EDT
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Currency in CAD

Valuation Measures

Premium required to access annual data
Annual
Quarterly
Premium required to access monthly data
Monthly
Subscribe to Premium to download historical data
 
As of Date: 10/24/2020
Current
6/30/20203/31/202012/31/20199/30/2019
Market Cap (intraday) 5
23.08M44.79M37.90M40.49M49.10M
Enterprise Value 3
15.54M35.31M26.38M26.22M31.06M
Trailing P/E
N/AN/AN/AN/AN/A
Forward P/E 1
N/AN/AN/AN/AN/A
PEG Ratio (5 yr expected) 1
N/AN/AN/AN/AN/A
Price/Sales (ttm)
N/AN/AN/AN/AN/A
Price/Book (mrq)
3.034.653.142.702.69
Enterprise Value/Revenue 3
N/AN/AN/AN/AN/A
Enterprise Value/EBITDA 6
-1.34-18.89-8.82-7.93-7.88

Trading Information

Stock Price History

Beta (5Y Monthly) 2.44
52-Week Change 3-46.67%
S&P500 52-Week Change 37.69%
52 Week High 314.1900
52 Week Low 34.0000
50-Day Moving Average 34.6643
200-Day Moving Average 37.0304

Share Statistics

Avg Vol (3 month) 36.86k
Avg Vol (10 day) 34.74k
Shares Outstanding 55.22M
Float 5.16M
% Held by Insiders 1N/A
% Held by Institutions 1N/A
Shares Short (Oct 14, 2020) 44.82k
Short Ratio (Oct 14, 2020) 41.26
Short % of Float (Oct 14, 2020) 4N/A
Short % of Shares Outstanding (Oct 14, 2020) 40.09%
Shares Short (prior month Sep 14, 2020) 44.92k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:33
Last Split Date 3Jul 02, 2020

Financial Highlights

Fiscal Year

Fiscal Year Ends Jun 29, 2020
Most Recent Quarter (mrq)Jun 29, 2020

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-50.41%
Return on Equity (ttm)-91.74%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -11.99M
Net Income Avi to Common (ttm)-11.86M
Diluted EPS (ttm)-2.2710
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)7.91M
Total Cash Per Share (mrq)1.52
Total Debt (mrq)431.98k
Total Debt/Equity (mrq)5.67
Current Ratio (mrq)3.77
Book Value Per Share (mrq)1.46

Cash Flow Statement

Operating Cash Flow (ttm)-9.77M
Levered Free Cash Flow (ttm)-5.66M